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ABSTRACT
Objective: The aim of this study was to formulate the floating gastroretentive of amoxicillin using hard alginate capsules shell and evaluate theantibacterial activities of floating gastroretentive of amoxicillin.
Methods: Amoxicillin was prepared in the solid dispersion form, it was prepared by a solvent method using polyvinylpyrrolidone (PVP) K30.The solid dispersion was characterized by X-ray diffraction and Fourier transformed infra-red analysis. The drug was filled into alginate capsuleshell. Drug release test was carried out using USP paddle method in simulated gastric fluid. Concentrations of amoxicillin were determined usingspectrophotometer ultraviolet at wavelength of 272 nm. The antibacterial activity of aliquots dissolution was assessed using agar plate diffusionmethod against Staphylococcus aureus and Escherichia coli as bacterial model.
Results: The dissolution test results showed that amoxicillin in the solid dispersions form with a weight ratio of amoxicillin and PVP K30 was 1:1caused sustained release of amoxicillin for 12 hrs, while the release of amoxicillin without solid dispersion was too slow. The floating lag time was0 minute and floating time was more than 12 hrs. The X-ray diffraction pattern of amoxicillin solid dispersion had amorphous shape. Antibacterialactivity test showed that the dissolution aliquots of amoxicillin solid dispersion were effective against S. aureus and E. coli.
Conclusions: Based on the results of this study, it is concluded that the alginate capsules shell can be used for the preparation of floating gastroretentiveof amoxicillin using amoxicillin solid dispersion and the dissolution aliquots give antibacterial effect.
Keywords: Floating, Gastroretentive, Alginate capsule, Amoxicillin, Solid dispersion, Release, Antibacterial.© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i5.17467
INTRODUCTION
Helicobacter pylori is believed to be the main cause of peptic ulcer dueto an imbalance between aggressive factors (H. pylori, nonsteroidal anti-inflammatory drugs [NSAIDs], and gastric acid) and defensive factors(mucin, bicarbonate, and prostaglandins), leading to disturbances inthe mucosal tissue [1]. The prevalence of peptic ulcers in developedcountries is 30-40%, while in developing countries is 80-90%. As manyas 48% of patients with peptic ulcers are caused by H. pylori infectionand 24% due to the use of NSAID drugs [2].Amoxicillin is a beta-lactam antibacterial, which has a broad-spectrumactivity against different types of infections caused by both Gram-positive and Gram-negative bacteria, including H. pylori by inhibitingthe process of cell wall synthesis [3]. Clinical studies using amoxicillinshow that amoxicillin is the least resistant compared to clarithromycinor metronidazole against H. pylori [4], but amoxicillin is ineffective evenat high dose when it is administered in conventional oral dosage formbecause the limited contact time [5]. The contact time of antibacterialdrug with organism should be long enough to be able to achievesuccessful eradication of H. pylori from gastric mucosa. Hence, asuitable pharmaceutical dosage form for H. pylori eradication is also animportant basic principle of the drug delivery system dominating theseconstraints and offering a proper delivery strategy [6].Several approaches of dosage formulations with gastroretentive systemhave been developed to achieve a controlled release of amoxicillin tostay longer in the stomach [7,8]. Floating system is a novel approachtoward gastroretentive drug delivery systems [9]. One of them isfloating drug delivery system or hydrodynamic system, a system that iscontrolled by the density of pharmaceutical dosage form that can float
on gastric fluid and the drug is slowly released on the desired level [10].In the previous study, it was reported that the formulation tablets ofamoxicillin and metronidazole in swellable effervescent floating tabletswere carried out as single and double layer tablets using polyethyleneglycol and hydroxypropyl methylcellulose polymers [11].Sodium alginate is a nontoxic polysaccharide that is derived fromseaweed (brown algae) [12]. Alginate can be used for the preparationof periodontal drug delivery system and gastroretentive drug deliverysystem of antacids [13-15]. In the previous study [16], it was reportedthe preparation and the characterization of hard alginate capsules’shell, and it was found that alginate capsules’ shell was resistant or didnot disintegrate in artificial gastric fluid (pH 1.2), but it swelled anddisintegrated in artificial intestinal fluid (pH 4.5 and pH 6.8).In this paper, it will be discussed the application of alginate capsulesshell as floating gastroretentive capsules, and amoxicillin was usedas a drug model. Amoxicillin was prepared in the solid dispersionform. The lag and floating time, drug release, antibacterial activity,and the characterization of amoxicillin solid dispersion will bediscussed.
MATERIALS AND METHODS
MaterialsAmoxicillin was obtained from PT. Mutifa, calcium chloride dihydrate,ethanol, and HCl were product of Merck. Sodium alginate 80-120 cP(Wako pure chemical industries, Ltd. Japan), polyvinylpyrrolidone(PVP) K30 (Nacalai tesque). Hard alginate capsules shell (size 0) wasobtained from Laboratory of Physical Pharmacy, Faculty of Pharmacy,University of Sumatera Utara.
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Table 1: The requirement of drug release for sustained release
products
Administration Time Amount Requirements [17]
interval (hrs) released (%)
Sterile papers’ disc was soaked in the samples for 30 minutes. Then,they were placed in the Petri dish containing Staphylococcus aureus0.25 D 3 24.84 20-50 and Escherichia coli culture inoculated in Mueller-Hinton agar media.0.5 D 6 50.65 45-75 The samples were incubated at 37°C for 18 hrs. After the incubation,1 D 12 90.80 ≥75 the zone of inhibition (ZOI) for standard dilution of amoxicillin andD: Dosing interval (12 hrs)
Table 2: The comparison of R2 values on the plots of zero‑order,
first‑order, and Higuchi model drug release
Kinetic order Linear equation R2 4DtZero-order y=0.133x+0.505 0.994 Where, MIC is minimum inhibitory concentration, x2 is zone ofOne order y=0.002x+0.525 0.698 inhibition (mm), C is the concentration of antibiotic (µg/mL), D is theHiguchi model y=3.994x-21.69 0.966 diffusion coefficient, and t is time required for antibiotic diffusion.
Methods
Preparation of amoxicillin solid dispersion
Drug releaseThe drug release test was performed using paddle method (100 rpm)in simulated gastric fluid (pH 1.2) at 37±0.5°C. The capsulescontained 500 mg amoxicillin or amoxicillin solid dispersionequivalent to 500 mg amoxicillin. In amoxicillin solid dispersionwas used two capsules of each capsule containing amoxicillin soliddispersion equivalent to 250 mg amoxicillin. Drug concentrationswere measured by ultraviolet spectrophotometer at a wavelength of272 nm (n=3).
Fourier transformed infra-red spectroscopy (FTIR)IR spectra were obtained using Shimadzu IR Prestige-21 spectrometer.The pulverized samples were micronized with KBr powder andmeasured in the range of 4000-400/cm.
X-ray diffraction analysis patternThe physicochemical properties of the solid dispersions wereinvestigated with X-ray diffraction (Shimadzu) using the source fromCu radiation. Observations were made on 2Ɵ, and the scanning speedwas 0.8000 per second.
Antibacterial activities assessmentThe antibacterial activity of amoxicillin solid dispersion wasperformed by agar plate diffusion method. First, the different dilutionof standard was prepared in simulated gastric fluid (pH 1.2) with aconcentration of 0-200 µg/mL. Then, the aliquots were taken fromdissolution experiment at 0, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 hrs.
The release of amoxicillin from floating hard alginate capsule is shownin Fig. 2.The release of pure amoxicillin from hard alginate capsules was tooslow as sustained release dosage form for 12 hrs dose interval anddid not meet the requirement of sustained release dosage form. Therequirement of sustained release dosage form is shown Table 1 [17].Therefore, to increase the release of amoxicillin, amoxicillin wasprepared in solid dispersion form. The release of amoxicillin from hardalginate capsules increased significantly in the solid dispersion formas shown in Fig. 2. In this case, the release of amoxicillin in the soliddispersion form fulfilled the requirement of sustained release dosageform for 12 hrs dose interval.In amoxicillin solid dispersion form, the dissolution rate of amoxicillinincreased  because  PVP  is  a water-soluble  polymer  that  enhancesthe wetting process of amoxicillin. In addition, the modification ofamoxicillin to amoxicillin solid dispersion form reduces the particlesize of amoxicillin so that the rate of dissolution increased.Hard alginate capsule shell which was placed in artificial gastric fluid(pH 1.2) remained in intact condition during drug release. This is
dissolution aliquot was measured with a calliper in mm scale. Theminimum inhibitory concentration (MIC) of amoxicillin was calculatedusing the following equation [7].
x2ln (MIC) = ln (C) − (1)
Fig. 1: Floating of hard alginate capsule containing amoxicillin during drug release experiment in simulated gastric fluid at 37°C. Arrow
shows the floating capsules
RESULTS AND DISCUSSIONS
Floating lag time, floating time, and drug releaseFloating lag time of hard alginate capsule containing amoxicillin was0 minute, it means that when capsule was immersed in simulatedgastric fluid pH 1.2, it floated immediately. The capsules floated duringdrug release experiment for 12 hrs as shown in Fig. 1. Capsules floatedwas due to the air entrapped inside of the alginate capsules shell andthe density of alginate capsules shell was lower than the density ofsimulated gastric fluid.
Solid dispersion of amoxicillin was prepared by solvent method withvarious weight ratio of amoxicillin to PVP K30 by dissolving amoxicillin,and PVP 30 in alcohol and the solvent was then evaporated at 40-50°Cuntil constant weight, stored for 24 hrs in desiccator. Scraped andcrushed and sieved using a sieve no. 12.
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caused by the content of alginate capsules 47.5% is calcium guluronatethat is insoluble in simulated gastric fluid (pH 1.2) [18]. Hard alginatecapsules disintegrate in the small intestine. Therefore, hard alginatecapsules can be used as floating gastroretentive drug delivery system.
Drug release kineticsThe drug-release data were analyzed to determine the drug releasekinetic. The kinetic release of amoxicillin solid dispersion from alginatecapsules shell was determined for zero-order, first-order, and Higuchimodel. The comparison of the correlation coefficient (R2) of amoxicillinrelease on the plot of zero-order, first-order, and Higuchi model drugrelease is presented in Table 2, and the plot for zero-order is shown inFig. 3. The plot of cumulative of drug released (%) versus time gives astraight line with the value of R2 is closer to one (0.994) compared to the
Fig. 2: Release of amoxicillin from floating hard alginate capsules
containing amoxicillin and amoxicillin solid dispersion in
simulated gastric fluid (pH 1.2) at 37°C for 12 hrs
R2 of other orders. It means that the release of amoxicillin from alginatecapsule follows zero-order release.
FTIR analysisThe FTIR spectrum results of amoxicillin showed that the absorptionband of O-H stretching vibration at 3525/cm, but the O-H stretchingvibration at 3525/cm of solid dispersion was disappeared (Fig. 4).Therefore, amoxicillin solid dispersion shows an interaction as theintermolecular hydrogen bond between amoxicillin and PVP K-30.
X‑ray analysisDiffractogram of pure amoxicillin showed crystalline shape (Fig. 5a),but PVP showed amorphous shape (Fig. 5b). Diffractogram of soliddispersion of amoxicillin-PVP (1:1) was the same with pure PVP, it wasan amorphous shape (Fig. 5c). X-ray diffraction analysis shows that thechange of amoxicillin’s crystal structure is caused by the formation ofhydrogen bonds between molecules of amoxicillin and PVP as verifiedby FTIR analysis (Fig. 4). A similar behavior is observed for curcuminsolid dispersion with PVP K-30 [19].
Scanning electron microscopy (SEM)SEM analysis shows that the surface of alginate capsule shell 80-120 cPis different between before and after dissolution for 12 hrs as shownin Fig. 6. After the dissolution test, the surfaces of capsule shows havemany pores.
Antibacterial activitiesThe photographs of antibacterial activity test of amoxicillin standardsolution with a concentration of 0-200 µg/ml on the growth of
S. aureus and E. coli using agar plate diffusion method are shown inFigs. 7 and 8 and the data experiment of amoxicillin standard solutionis listed in Table 3. The ZOI increased with increasing antibioticconcentrations.
Determination of MIC of amoxicillinEquation (1) as shown previously is revealed to be:x2ln (C) = ln (MIC) + 4Dt (2)From Equation (2), the plot of ln C versus x2 is made and is obtaineda straight line as shown in Figs. 9 and 10. The intercept of the lineequation is ln MIC, then the value of MIC of a standard solution ofamoxicillin is obtained.
Fig. 3: A zero‑order plot of amoxicillin release from floating hard
alginate capsules shell in the medium of simulated gastric fluid
(pH 1.2) at 3°C
Plots   on   Figs.   9   and   10   give   straight   line   and   the   correlationcoefficient (R2) are 0.990 and 0.993 (good linearity relationship).Values of intercept from the equation, ln MIC is −0.018 and −0.096;therefore, the MIC values of amoxicillin against S. aureus and E. coli are0.982 µg/mL and 0.909 µg/mL, respectively.
Fig. 4: Infrared spectrograms of amoxicillin as pure chemical and as solid dispersion (amoxicillin‑polyvinylpyrrolidone [PVP]), and PVP
only
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Fig. 5: Diffractograms of amoxicillin (a), polyvinylpyrrolidone (PVP) (b), and solid dispersion amoxicillin‑PVP(c)
a b
Fig. 6: Scanning electron microscopy of alginate capsule shell.
(a) initial and (b) after drug release experiment
Fig. 9: Plot ln C versus x2 of amoxicillin standard solution against
Staphylococcus aureus
Fig. 7: Zone of inhibition of amoxicillin standard solution against
Staphylococcus aureus Fig.10: Plot of ln C versus x2 of amoxicillin standard solution
against Escherichia coli
Antibacterial activities of dissolution aliquot of amoxicillin solid
dispersionThe photographs of dissolution aliquots effect on the growth of
S. aureus and E. coli with agar diffusion method are shown inFigs. 11 and 12 and the data experiment is listed in Table 4. Table 4shows the antibacterial activities of dissolution aliquots containingamoxicillin-PVP K30 (1:1) solid dispersion which is released fromalginate capsule. The dissolution aliquots inhibited the growthof S. aureus with ZOI increased from 0.27±0.03 to 6.94±0.48 mmand inhibited the growth of E. coli with ZOI from 0.37±0.17 to6.04±0.84 mm.
Fig. 8: Zone of inhibition of amoxicillin standard solution against
Escherichia coli
The results showed that the ZOI for S. aureus was not much differentwith ZOI for E. coli. Amoxicillin is a broad-spectrum antibiotic thatis effective against bacteria both Gram-negative and Gram-positivebacteria [3]. ZOI of amoxicillin solid dispersion against S. aureus and
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Table 3: Antibacterial activities of standard solution of amoxicillin against S. aureus and E. coli
Concentrations (µg/mL) (C) S. aureus E. coli
ln (C) ZOI (mm) (x) x2 ln (C) ZOI (mm) (x) x20 0.000 0.000 0.000 0.000 0.000 0.0000,5 −0.693 0.067 0.004 −0.693 0.033 0.0011 0.000 0.167 0.028 0.000 0.300 0.0902 0.693 1.300 1.690 0.693 1.367 1.8683 1.099 1.800 3.240 1.099 1.700 2.8904 1.386 2.267 5.138 1.386 1.900 3.6105 1.609 2.500 6.250 1.609 2.067 4.27110 2.303 2.993 8.960 2.303 2.467 6.08420 2.996 3.367 11.334 2.996 2.767 7.65440 3.689 3.767 14.188 3.689 3.167 10.02860 4.094 4.000 16.000 4.094 3.400 11.56080 4.382 4.133 17.084 4.382 3.467 12.018100 4.605 4.233 17.921 4.605 3.533 12.484120 4.787 4.333 18.778 4.787 3.633 13.201140 4.942 4.433 19.654 4.942 3.667 13.444160 5.075 4.467 19.951 5.075 3.700 13.690180 5.193 4.567 20.854 5.193 3.767 14.188200 5.298 4.533 20.551 5.298 3.767 14.188ZOI: Zone of inhibition, S. aureus: Staphylococcus aureus, E. coli: Escherichia coli
Table 4: Antibacterial activities of dissolution aliquot of
amoxicillin solid dispersion
Time (hrs) ZOI (mm)
Staphylococcus aureus Escherichia coli0 0.00±0.00 0.00±0.000,5 0.27±0.03 0.37±0.171 0.80±0.24 0.91±0.322 1.08±0.30 1.44±0.083 1.88±0.23 2.01±0.074 2.48±0.41 2.51±0.185 3.09±0.70 3.07±0.306 3.62±0.95 3.71±0.597 4.11±0.92 4.20±0.758 4.56±0.92 4.51±0.899 5.07±0.80 4.88±0.7910 5.62±0.77 5.32±0.9611 6.13±0.63 5.71±0.8612 6.94±0.48 6.04±0.84ZOI: Zone of inhibition Fig. 11: Zone of inhibition of dissolution aliquot of amoxicillinsolid dispersion against Staphylococcus aureus
E. coli increased with increasing time of dissolution due to the increaseof amoxicillin concentration in the solution.
Correlation of ZOI of aliquot dissolution of amoxicillin solid
dispersion with calculated ZOI of standard solutionCalculated ZOI values of standard solution for S. aureus are listed inTable 5. Calculated ZOI of standard solution was obtained by insertingthe ln C values of dissolution aliquot of solid dispersion into theregression equation of the graph of Fig. 9 to obtain the calculated ZOIof standard solution for S. aureus. The same method of ln C values ofTable 6 is inserted to the regression equation of the graph of Fig. 10 toobtain the calculated ZOI of standard solution for E. coli. Calculated ZOIvalues of standard solution for E. coli are listed in Table 6.The correlation of ZOI of aliquot dissolution of amoxicillin soliddispersion  with ZOI  of  standard  solution  (calculated)  is  shown  inFig. 13a for S. aureus and Fig. 13b for E. coli. As shown in Fig. 13, the plotof ZOI of dissolution aliquot of amoxicillin solid dispersion versus ZOIof standard solution (calculated) gives a straight line with R2 is 0.999. Itmeans that there is a high correlation between ZOI of standard solutionand ZOI of dissolution aliquot of amoxicillin solid dispersion. Thisindicates that the inhibitory effect of amoxicillin standard solution anddissolution aliquot of amoxicillin release from floating alginate capsulesis not different against S. aureus and E. coli.
Fig. 12: Zone of inhibition of dissolution aliquot of amoxicillin
solid dispersion against Escherichia coli
CONCLUSIONSHard alginate capsules shell can be used to obtain a sustained release offloating gastroretentive of amoxicillin, but amoxicillin should be used in
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Table 5: ZOI of dissolution aliquot of amoxicillin solid dispersion and standard solution (calculated) against Staphylococcus aureus
Dissolution aliquot Standard solution (calculated)
Time (hrs) ZOI (mm) (x) C ln C (y) x2 ZOI (mm) (x)0 0.00 0.982 −0.00 0.00 0.0000.5 0.27 1.000 0.00 0.07 0.2681 0.80 1.168 0.16 0.68 0.8232 1.08 1.342 0.29 1.22 1.1053 1.88 2.443 0.89 3.56 1.8864 2.48 4.864 1.58 6.25 2.5005 3.09 12.295 2.51 9.87 3.1416 3.62 32.959 3.50 13.72 3.7047 4.11 85.777 4.45 17.46 4.1788 4.56 230.249 5.44 21.32 4.6179 5.07 783.068 6.66 26.10 5.10810 5.62 3549.524 8.17 32.00 5.65711 6.13 16004.215 9.68 37.89 6.15512 6.94 235007.995 12.37 48.38 6.955ZOI: Zone of inhibition
Tabel 6: ZOI of dissolution aliquot of amoxicillin solid dispersion and standard solution (calculated) against Escherichia coli
Dissolution aliquot Standard solution (calculated)
Time (hrs) ZOI (mm) (x) C ln C (y) x2 ZOI (mm) (x)0 0.00 0.000 −0.000 0.00 0.0000.5 0.37 0.968 −0.032 0.17 0.4121 0.91 1.317 0.275 0.99 0.9942 1.44 2.149 0.765 2.29 1.5133 2.01 4.397 1.481 4.19 2.0484 2.51 10.112 2.313 6.41 2.5315 3.07 32.574 3.483 9.52 3.0856 3.71 180.320 5.194 14.07 3.7517 4.20 814.097 6.702 18.08 4.2528 4.51 2410.204 7.787 20.97 4.5789 4.88 8255.688 9.018 24.24 4.92310 5.32 49642.150 10.812 29.01 5.38611 5.71 236530.185 12.373 33.16 5.75812 6.04 1014802.37 13.830 37.04 6.085ZOI: Zone of inhibition
a b
Fig. 13: Correlation plot of zone of inhibition (ZOI) of dissolution aliquot of amoxicillin solid dispersion versus ZOI of standard solution
against Staphylococcus aureus (a) and Escherichia coli (b)the solid dispersion form. The release of pure amoxicillin (without soliddispersion) is too slow. Therefore, amoxicillin should be formulated inthe solid dispersion form. Hard alginate capsules containing amoxicillinsolid dispersion are immediately float and it float during the dissolutionexperiment for 12 hrs. The dissolution aliquots of amoxicillin soliddispersion inhibit the growth of S. aureus and E. coli.
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